11 December 2020: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announces that, at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders.
11 December 2020: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announces that, at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders.